aTyr Pharma Inc Banner Image

aTyr Pharma Inc

  • Ticker LIFE
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
aTyr Pharma Inc Logo Image
  • 51-200 Employees
  • Based in San Diego, California
aTyr Pharma, Inc. engages in the discovery and clinical development of protein based therapeutics for patients suffering from severe and rare diseases. The company is developing Resolaris, which is in Phase Ib/II clinical trials in adult patients with facioscapulohumeral muscular dystrophy, a rare genetic myopathy with an immune component. Its products pipeline also includes Resolaris forMore treatment of patients with early onset facioscapulohumeral muscular dystrophy, a rare genetic myopathy with an immune component and limb-girdle muscular dystrophies, as well as rare pulmonary diseases with an immune component. In addition, the company is developing iMod.Fc, a preclinical immuno-modulatory domain program. The company was founded in 2005 and is headquartered in San Diego, California.
aTyr Pharma Inc

Most Recent Responsibility Report


aTyr Pharma Inc does not currently have any reports on ResponsibilityReports.com. Click the button below to be notified when financial info becomes available.

Request Information
Our service enables potential investors to review the most recent and archived aTyr Pharma Inc Sustainability Report, aTyr Pharma Inc Corporate Social Responsibility Report, aTyr Pharma Inc CSR Report, aTyr Pharma Inc Corporate Responsibility, aTyr Pharma Inc CR Report, aTyr Pharma Inc Citizenship Report, aTyr Pharma Inc ESG Report, and aTyr Pharma Inc Environmental Report online.